The company has at least 5-7 open Ridaforolimus trials going right now, and they had nothing to speak about, whatsoever, at ESMO Any news regarding rida will come form MRK not Ariad. Perhaps you should direct your complaint about the lack of PR to the investorshub.advfn.com/boards/board.aspx?board_id=6131 MRK board.